vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Natural Grocers by Vitamin Cottage, Inc. (NGVC). Click either name above to swap in a different company.
Natural Grocers by Vitamin Cottage, Inc. is the larger business by last-quarter revenue ($335.6M vs $196.0M, roughly 1.7× Axsome Therapeutics, Inc.). Natural Grocers by Vitamin Cottage, Inc. runs the higher net margin — 3.4% vs -14.6%, a 17.9% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 1.6%). Natural Grocers by Vitamin Cottage, Inc. produced more free cash flow last quarter ($11.6M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 4.4%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Natural Grocers by Vitamin Cottage, Inc. is a U.S.-based specialty retail chain that offers certified organic groceries, dietary supplements, natural personal care items, and eco-friendly household products. It serves health-conscious consumers across multiple U.S. states, following strict quality standards that exclude artificial preservatives, colors, flavors and harmful additives.
AXSM vs NGVC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $335.6M |
| Net Profit | $-28.6M | $11.3M |
| Gross Margin | — | 29.5% |
| Operating Margin | -13.8% | 4.4% |
| Net Margin | -14.6% | 3.4% |
| Revenue YoY | 65.0% | 1.6% |
| Net Profit YoY | 61.9% | 14.0% |
| EPS (diluted) | $-0.55 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $335.6M | ||
| Q3 25 | $171.0M | $336.1M | ||
| Q2 25 | $150.0M | $328.7M | ||
| Q1 25 | $121.5M | $335.8M | ||
| Q4 24 | $118.8M | $330.2M | ||
| Q3 24 | $104.8M | $322.7M | ||
| Q2 24 | $87.2M | $309.1M | ||
| Q1 24 | $75.0M | $308.1M |
| Q4 25 | $-28.6M | $11.3M | ||
| Q3 25 | $-47.2M | $11.8M | ||
| Q2 25 | $-48.0M | $11.6M | ||
| Q1 25 | $-59.4M | $13.1M | ||
| Q4 24 | $-74.9M | $9.9M | ||
| Q3 24 | $-64.6M | $9.0M | ||
| Q2 24 | $-79.3M | $9.2M | ||
| Q1 24 | $-68.4M | $8.0M |
| Q4 25 | — | 29.5% | ||
| Q3 25 | — | 29.5% | ||
| Q2 25 | — | 29.9% | ||
| Q1 25 | — | 30.3% | ||
| Q4 24 | — | 29.9% | ||
| Q3 24 | — | 29.6% | ||
| Q2 24 | — | 29.2% | ||
| Q1 24 | — | 29.3% |
| Q4 25 | -13.8% | 4.4% | ||
| Q3 25 | -27.0% | 4.6% | ||
| Q2 25 | -24.5% | 4.7% | ||
| Q1 25 | -46.9% | 5.2% | ||
| Q4 24 | -61.1% | 4.0% | ||
| Q3 24 | -59.8% | 3.7% | ||
| Q2 24 | -89.5% | 4.2% | ||
| Q1 24 | -89.7% | 3.7% |
| Q4 25 | -14.6% | 3.4% | ||
| Q3 25 | -27.6% | 3.5% | ||
| Q2 25 | -32.0% | 3.5% | ||
| Q1 25 | -48.9% | 3.9% | ||
| Q4 24 | -63.1% | 3.0% | ||
| Q3 24 | -61.7% | 2.8% | ||
| Q2 24 | -91.0% | 3.0% | ||
| Q1 24 | -91.1% | 2.6% |
| Q4 25 | $-0.55 | $0.49 | ||
| Q3 25 | $-0.94 | $0.51 | ||
| Q2 25 | $-0.97 | $0.50 | ||
| Q1 25 | $-1.22 | $0.56 | ||
| Q4 24 | $-1.54 | $0.43 | ||
| Q3 24 | $-1.34 | $0.38 | ||
| Q2 24 | $-1.67 | $0.40 | ||
| Q1 24 | $-1.44 | $0.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $23.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $220.0M |
| Total Assets | $689.8M | $668.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $23.2M | ||
| Q3 25 | $325.3M | $17.1M | ||
| Q2 25 | $303.0M | $13.2M | ||
| Q1 25 | $300.9M | $21.2M | ||
| Q4 24 | $315.4M | $6.3M | ||
| Q3 24 | $327.3M | $8.9M | ||
| Q2 24 | $315.7M | $13.9M | ||
| Q1 24 | $331.4M | $11.0M |
| Q4 25 | $88.3M | $220.0M | ||
| Q3 25 | $73.7M | $212.4M | ||
| Q2 25 | $73.1M | $202.5M | ||
| Q1 25 | $53.2M | $193.0M | ||
| Q4 24 | $57.0M | $181.9M | ||
| Q3 24 | $92.9M | $174.3M | ||
| Q2 24 | $102.9M | $167.8M | ||
| Q1 24 | $144.0M | $160.0M |
| Q4 25 | $689.8M | $668.6M | ||
| Q3 25 | $669.3M | $670.5M | ||
| Q2 25 | $639.8M | $659.0M | ||
| Q1 25 | $596.7M | $664.6M | ||
| Q4 24 | $568.5M | $648.9M | ||
| Q3 24 | $561.5M | $655.5M | ||
| Q2 24 | $548.2M | $654.4M | ||
| Q1 24 | $545.7M | $656.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $21.1M |
| Free Cash FlowOCF − Capex | $-18.7M | $11.6M |
| FCF MarginFCF / Revenue | -9.6% | 3.4% |
| Capex IntensityCapex / Revenue | 0.0% | 2.9% |
| Cash ConversionOCF / Net Profit | — | 1.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $42.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $21.1M | ||
| Q3 25 | $1.0M | $15.6M | ||
| Q2 25 | $-32.4M | $2.9M | ||
| Q1 25 | $-43.4M | $34.1M | ||
| Q4 24 | $-26.2M | $2.7M | ||
| Q3 24 | $-18.6M | $24.5M | ||
| Q2 24 | $-30.1M | $12.4M | ||
| Q1 24 | $-53.5M | $20.2M |
| Q4 25 | $-18.7M | $11.6M | ||
| Q3 25 | $988.0K | $7.5M | ||
| Q2 25 | $-32.4M | $-4.2M | ||
| Q1 25 | $-43.7M | $27.6M | ||
| Q4 24 | $-26.2M | $-6.9M | ||
| Q3 24 | $-18.7M | $18.0M | ||
| Q2 24 | $-30.2M | $3.6M | ||
| Q1 24 | $-53.6M | $9.8M |
| Q4 25 | -9.6% | 3.4% | ||
| Q3 25 | 0.6% | 2.2% | ||
| Q2 25 | -21.6% | -1.3% | ||
| Q1 25 | -36.0% | 8.2% | ||
| Q4 24 | -22.1% | -2.1% | ||
| Q3 24 | -17.9% | 5.6% | ||
| Q2 24 | -34.6% | 1.2% | ||
| Q1 24 | -71.4% | 3.2% |
| Q4 25 | 0.0% | 2.9% | ||
| Q3 25 | 0.0% | 2.4% | ||
| Q2 25 | 0.0% | 2.2% | ||
| Q1 25 | 0.3% | 1.9% | ||
| Q4 24 | 0.0% | 2.9% | ||
| Q3 24 | 0.1% | 2.0% | ||
| Q2 24 | 0.1% | 2.9% | ||
| Q1 24 | 0.1% | 3.4% |
| Q4 25 | — | 1.86× | ||
| Q3 25 | — | 1.32× | ||
| Q2 25 | — | 0.25× | ||
| Q1 25 | — | 2.60× | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | 2.72× | ||
| Q2 24 | — | 1.35× | ||
| Q1 24 | — | 2.54× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AXSM
Segment breakdown not available.
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
